Breast Cancer Market 2021 Ecosystem Player Profiles, Value Chain and Industry Strategies to 2030
Report sample URL
The breast cancer drug market is estimated to reach US $ 46.76 billion by 2030 from a market value of US $ 23.75 billion in 2022 and is expected to grow at a CAGR of 10.16% during the 2022-2030 forecast period.
Breast cells can start to grow out of control, leading to breast cancer. These cells generally form tumors that can be felt as lumps. This can be further confirmed using the mammogram. Increased incidence of breast cancer due to factors such as overexposure to endogenous estrogen, early onset, and late birth and late menopause has a significant impact on the growth of the breast cancer drug market. The development of cancer biology technology and the introduction of a range of diagnostic and screening programs around the world may drive the growth of the breast cancer treatment market. In addition, increased acceptance of treatments for breast cancer is due to factors such as blocking the binding of estrogen to tumor cells, the risk of distant recurrence, the reduced risk of recurrence in the breast with the tumor, and the reduced risk of developing the disease. It contributes to the growth of the therapeutic drug market.
In addition, increasing awareness of breast cancer, increasing shifts to Western lifestyle adoption, limited breastfeeding periods, and the prevalence of obesity in postmenopausal women are driving the size of the industry. Increased female alcohol intake, increased use of hormone replacement therapy (HRT), and increased use of oral contraceptives that increase estrogen levels are creating growth opportunities for the breast cancer treatment market. WHO reports that breast cancer affects about 2.1 million people annually and is the leading cause of malignant tumor-related deaths. However, the exorbitant costs associated with the use of breast cancer treatment can hinder the growth of the breast cancer drug market.
Details of the survey report
Breast Cancer Therapeutics Market Segment
The breast cancer drug market is divided by product (hormone drug, chemotherapeutic drug, targeted drug therapy), distribution channel (hospital, outpatient surgery center, clinic, e-commerce, retail pharmacy), and region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.
Regional Overview of the Breast Cancer Treatment Market
The North American region had the largest market share in 2018. This is due to the increased incidence of breast cancer and increased support for research and development across the public and private sectors. In addition, an increasing elderly population, early-onset breastfeeding, and increased access to cancer treatments are expected to drive growth in the region's breast cancer drug market. In addition, the growing demand for tumor treatment will strongly support the growth of industry in the region. Meanwhile, the Asia Pacific breast cancer market is expected to grow at the largest CAGR during the forecast period. Initiatives by various organizations to raise awareness of the disease, educate people and raise funds are expected to drive the growth of the regional breast cancer drug market.
Report sample URL
These regional segments are North America (US and Canada); Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Singapore, Other Asia Pacific); Latin America (Brazil, Mexico, Argentina, etc.) Latin America); Middle East and Africa (Israel, GCC [Saudi Arabia, Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa) and Europe (UK, Germany, France, Italy) , Spain, Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia and other Europe) and more.
Key Players in the Breast Cancer Market
Key Players in the Breast Cancer Market include AstraZeneca, Bristol-Myers Squibb, Eisai Co. Ltd, Eli Lilly and Company, Genentech, GlaxoSmithKline, Halozyme Inc., Novartis AG, Pfizer. Inc., Genzyme Corporation, etc. The study includes in-depth competitive analysis, corporate profiles, recent developments, and key market strategies for these major companies in the breast cancer market.
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
SDKI Inc. Company Profile
SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Breast Cancer Market 2021 Ecosystem Player Profiles, Value Chain and Industry Strategies to 2030 here
News-ID: 2527680 • Views: 161
More Releases from SDKI
Artificial Corneal and Corneal Implant Market 2022 Industry Key Player, Trend an …
SDKI Inc. aims to provide a detailed analysis of several aspects of the market, including market growth drivers, opportunities, recent trends and challenges between 2021 and 2026. The artificial corneal and corneal implant market. Report sample URL https://www.sdki.jp/sample-request-112023 The global artificial corneal and corneal implant market is estimated to reach US $ 599 million by 2026 from US $ 418 million in 2021 and is projected to grow at a CAGR of 7.4%
Fiber Optic Components Market 2022 Industry Challenges, Top Manufacturers, Key C …
SDKI Inc. published a new research report on Fiber Optic Components Market-Growth, Trends, and Forecasts 2025. The report provides a complete assessment of the market and its growth prospects, along with new business opportunities in the industry. It also includes market size and annual growth during the 2020-2025 forecast period. Report sample URL https://www.sdki.jp/sample-request-90601 The fiber optic component market is expected to grow at a CAGR of 10.7% during the forecast period of
Semiconductor and Electronic Components Manufacturing Market 2022 Driving Factor …
SDKI Inc. aims to provide a detailed analysis of several aspects of the market, including market growth drivers, opportunities, recent trends and challenges between 2020-2025, in the semiconductor and electronic component manufacturing market. Report sample URL https://www.sdki.jp/sample-request-90604 The semiconductor and electronic component manufacturing market is projected to register a CAGR of 7.12% during the forecast period of 2020-2025. Miniaturization and high demand for high performance and energy efficient electronic devices for applications
Thermal paper Market 2022 Opportunity Assessment, Business Opportunities, Top In …
SDKI Inc. published a new report on the thermal paper market. This study includes the statistical and analytical approaches needed to grow the thermal paper market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth. Report sample URL https://www.sdki.jp/sample-request-90608 The thermal paper market is
More Releases for Breast
Breast Reduction Bangalore
The Pros and Cons of a Breast Reduction: All of these symptoms can be a telltale sign your breasts are too heavy for your frame: Pressure on the shoulders caused by bra straps supporting too much weight. Severe back and neck pain. Numbness in your hands and fingers. Headaches. Shortness of breath. Breast reduction is a surgical procedure that reduces the size and weight of the breasts. It has proven to be a popular solution to alleviate
Soaring Instances of Breast Cancer to Propel Breast Imaging Market
"The Report Breast Imaging Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 - MarketResearchReports.biz" An intelligence report on the global breast imaging market has been added to the burgeoning portfolio of MarketResearchReports.biz. Titled, “Breast Imaging Market (Mammography, Breast MRI, Breast Ultrasound, Tomosynthesis, Nuclear Imaging and Others [Breast Thermography & Bioelectric Imaging]) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” the
What Is A Combined Breast Augmentation With Breast Lift?
Combined Breast Augmentation And Lift: How Is It Performed? Surrounding the areola one incisions is made to remove the excess skin and another vertically incisions is made to the base of breasts starting from low part of the areola. Sometimes the scar is referred to as the “Lollipop scar”. Implants are placed through the incisions made and positioned carefully by the surgeon under the pectoral chest muscle, where the implants can
Global Breast Pumps Market
The Global Breast Pumps Market was valued at US$ 606.6 million in 2015 and is projected to expand at a CAGR of 4.8% during 2016–2024,according to a new report published by Coherent Market Insights. Rapidly growing population and improving insurance scenario is propelling demand for breast pumps worldwide. Demand for electronic breast pumps is gaining high traction in terms mainly due to adjustable suction level aiding ease of use. A more
Liposuction Breast Reduction
Portsmouth, NH - Liposuction Breast Reduction, also known as Scarless Breast Reduction continues to gain in popularity over the traditional method of breast reduction for the relief of back, neck and shoulder pain. More and more patients are dissatisfied with the older method and are requesting the less invasive method over the twelve inches of scarring per breast. Plastic Surgeons are responding to their patients and are performing more and
Breast Cancer-Breast Conservation Is A Possibility
New Delhi - April 27, 2011: The incidence of breast cancer is rapidly increasing in India and has overtaken cancer of cervix in Indian women in metropolitan cities. One in 22 Indian women are likely to develop breast cancer during their lifetime. Breast cancer is a disease of old age with the peak incidence in the fifth and sixth decades - but in India the disease is seen a decade